Table 4.

Proportions of patients with various haematological abnormalities that recovered after 4, 12, 24 and 52 weeks of treatment with telitacicept

	4 weeks	12 weeks	24 weeks	52 weeks
Patients without haemolysis	n=22	n=22	n=22	n=8
Recovered after treatment, n (%)	8 (36.36)	10 (45.45)	15 (68.18)	7 (87.5)
Patients with haemolysis	n=7	n=7	n=7	n=2
Recovered after treatment, n (%)	2 (28.57)	4 (57.14)	4 (57.14)	1 (50.00)
Patients with thrombocytopenia	n=15	n=15	n=15	n=3
Recovered after treatment, n (%)	6 (40.00)	8 (53.33)	12 (80.00)	2 (66.67)
Patients with leucopenia	n=9	n=9	n=9	n=0
Recovered after treatment, n (%)	8 (88.89)	8 (88.89)	8 (88.89)	–